Pubblicazioni ufficiali argenx SE

Azioni

Mercato chiuso - Euronext Bruxelles Altri mercati azionari 17:35:02 24/04/2024			Dopo chiusura 19:16:11
349,9 ^EUR	+0,20%		350,2	+0,09%

17/04	I titoli azionari europei scambiati negli Stati Uniti come ricevute americane di deposito sono in calo mercoledì mattina	MT
16/04	Argenx SE annuncia i dati dello studio di Fase 3 ADHERE che valuta VYVGART Hytrulo nei pazienti con polineuropatia infiammatoria cronica demielinizzante	CI

Mixed general shareholder meeting	26/03	CO
SEC Filing 20 F	21/03	CO
Annual ESG Report	21/03	CO
Annual Report	21/03	CO
SEC Filing 13G	29/02	CO
SEC Filing 6K-4	29/02	CO
Slide show results	29/02	CO
Annual results	29/02	CO
Threshold crossings	01/02	CO
Threshold crossings	31/01	CO
Threshold crossings	26/01	CO
Admission of new securities	31/12	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	19/12	CO
Threshold crossings	01/11	CO
Slide show Q3	31/10/23	CO
3rd quarter results	31/10/23	CO
SEC Filing 6K-3	31/10/23	CO
Threshold crossings	20/10/23	CO
Admission of new securities	30/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	20/09/23	CO
Threshold crossings	19/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	15/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	12/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	08/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	31/08/23	CO